Fagron SA FAGR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €22.60
- Day Range
- €22.50–22.85
- 52-Week Range
- €19.72–25.30
- Bid/Ask
- €22.45 / €22.95
- Shares Outstanding
- 73.39M
- Market Cap
- €1.65B
- Volume/Avg
- 61,829 / 86,726
Key Statistics
- Price/Earnings (Normalized)
- 17.41
- Price/Sales
- 1.61
- Dividend Yield (Trailing)
- 1.78%
- Dividend Yield (Forward)
- 1.78%
- Dividend Payment Schedule
- May
- Total Yield
- 1.78%
Company Profile
Fagron SA is a Belgium-based multinational pharmaceutical compounding company specializing in pharmaceutical compounding. It operates across the pharmaceutical compounding value chain, developing and manufacturing personalized medicines in collaboration with pharmacists, prescribers, hospitals, and other healthcare providers. The company has three segments: Essentials, Brands, and Compounding Services. The majority of the revenue is derived from the Essentials segment, which provides raw materials, equipment, packaging, and supplies for compounding to pharmacies and healthcare industries across EMEA, Latin America, and North America - Pacific. Geographically, it generates the maximum revenue from Fagron North America - Pacific.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 4,880
- Website
- https://www.fagron.com
Valuation
|
Metric
|
FAGR
|
|---|---|
Price/Earnings (Normalized) | 17.41 |
Price/Book Value | 2.79 |
Price/Sales | 1.61 |
Price/Cash Flow | 11.54 |
Price/Earnings
FAGR
Financial Strength
|
Metric
|
FAGR
|
|---|---|
Quick Ratio | 0.91 |
Current Ratio | 1.77 |
Interest Coverage | 5.21 |
Quick Ratio
FAGR
Profitability
|
Metric
|
FAGR
|
|---|---|
Return on Assets (Normalized) | 7.27% |
Return on Equity (Normalized) | 17.45% |
Return on Invested Capital (Normalized) | 10.57% |
Return on Assets
FAGR
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|XRq#%XV | LOCK|%^?vd | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|ksP&Wyk | LOCK|?Nk$ | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|tzDqSG | LOCK|<k | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|@mvt!#Wb | LOCK|j> | $29B | |||
| Viatris Inc
VTRS
| LOCK|l$#Wvx | LOCK|Nm | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|?Q | LOCK|%r% | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|jmKyk?M | LOCK|lk | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|Z<&$$@ | LOCK|PV% | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|JBh?$$V | LOCK|hVLqX | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|m<?K&< | LOCK|<> | $2B |
United States